Simponi 50 MG/0.5 ML pen injec 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FPVGC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,154
Award facts
- Contract value 100% obligated
- $12,154.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,154.49 to AmerisourceBergen Drug Corp for SIMPONI 50 mg/0.5 mL pen injections (0.5 mL units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SIMPONI is a biologic medication used primarily to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, supporting the Defense Health Agency's pharmaceutical supply chain for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military personnel and veteran healthcare needs globally. The company's competitive positioning in federal procurement is evidenced by its consistent receipt of non-set-aside awards across multiple therapeutic domains, demonstrating its capability to meet stringent federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DB26FPVGC?
SPE2DB26FPVGC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FPVGC worth?
The government has obligated $12,154 on SPE2DB26FPVGC.
Is contract SPE2DB26FPVGC an order under another contract?
Yes. SPE2DB26FPVGC is a delivery order under SPE2DB25D3003, an indefinite delivery contract.
Was contract SPE2DB26FPVGC competed?
The extent of competition for SPE2DB26FPVGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award